期刊文献+

甲状腺癌骨转移模型的研究

Research progress of animal model of bone metastases of thyroid carcinoma
原文传递
导出
摘要 甲状腺癌是内分泌系统最常见的恶性肿瘤,其发病率逐年上升,虽然该病预后较好,但若发生骨转移,患者10年生存率将明显降低。目前,甲状腺癌发生骨转移的机制尚不明确,对甲状腺癌骨转移的研究不仅具有重要的临床价值,也有很重要的科研价值。甲状腺癌骨转移动物模型的建立是研究甲状腺癌骨转移机制和治疗的基础,根据其建立方法可分为自发性、化学诱导性、转基因诱导性和移植性4种。 Thyroid carcinoma is the most common endocrine malignancy, its incidence rate increases year by year. Although the disease has good prognosis, if bone metastases happen, 10-year survival rate of patients will obviously reduce. At present, the mechanism of the occurrence of bone metastases is not clear. The research of bone metastases of thyroid carcinoma not only has important clinical value, but also scientific value. Animal model of bone metastasis of thyroid carcinoma is the basis to study the mechanism and therapy of thyroid carcinoma. According to its establishment methods, it can be divided into four types, including spontaneous type, chemical induced type, transgenic induced type and transplanted type.
作者 亓龙 王辉
出处 《国际放射医学核医学杂志》 2010年第6期329-332,共4页 International Journal of Radiation Medicine and Nuclear Medicine
关键词 甲状腺肿瘤 肿瘤转移 模型 动物 Thyroid neoplasms Neoplasm metastasis Models, animal
  • 相关文献

参考文献34

  • 1Sciuto R, Romano L, Rea S, et al. Natural history and clinical outcome of differentiated thyroid carcinoma: a retrospective analysis of 1503 patients treated at a single institution. Ann Oncol, 2009, 20(10): 1728-1735. 被引量:1
  • 2Muresan MM, Olivier P, Leclere J, et al. Bone metastases from differentiated thyroid carcinoma. Endocr Relat Cancer, 2008, 15(1): 37-49. 被引量:1
  • 3Mihailovic JM, Stefanovic LJ, Malesevic MD, et al. Metastatic differentiated thyroid carcinoma: clinical management and outcome of disease in patients with initial and late distant metastases. Nucl Med Commun, 2009, 30(7): 558-564. 被引量:1
  • 4Durante C, Haddy N, Baudin E, et al. Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: benefits and limits of radioiodine therapy. J Clin Endocrinol Metab, 2006, 91 (8): 2892-2899. 被引量:1
  • 5Schlumberger M, Tubiana M. De Vathaire F, et al. Long-term results of treatment of 283 patients with lung ang bone metastases from differentiated thyroid carcinoma. J Clin Endocrinol Metab, 1986, 63(4):960-967. 被引量:1
  • 6Sugltani I, Fujimoto Y, Yamamoto N, et al. Papillary thyroid carcinoma with distant metastases: survival predictors and the importance of local control. Surgery, 2008, 143(1): 35-42. 被引量:1
  • 7Baitei EY, Zou M, A1-Mohanna F, et al. Aberrant BRAF splicingas an alternative mechanism for oncogenic B-Raf activation in thyroid carcinoma. J Pathol, 2009, 217(5): 707-715. 被引量:1
  • 8Kogai T, Sajid-Crockett S, Newmarch LS, et al. Phosphoinositide3-kinase inhibition induces sodium/iodide symporter expression in rat thyroid ceils and human papillary thyroid cancer cells. J Endocrinol, 2008, 199(2): 243-252. 被引量:1
  • 9Ahn SH, Henderson Y, Kang Y, et al. An orthotopic model of papillary thyroid carcinoma in athymic nude mice. Arch Otolaryngol Head Neck Surg, 2008, 134(2): 190-197. 被引量:1
  • 10Younes MN, Kim S, Yigitbasi OG, et al. Integrin-linked kinase is a potential therapeutic target for anaplastic thyroid cancer. Mol Cancer Ther, 2005, 4(8): 1146-1156. 被引量:1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部